The latest development in the healthcare class-action settlement will affect approximately 900,000 physicians (and some major state medical societies) who may be eligible to receive compensation from the settlement – as long as they file a claim. The case has been called “historic” by those representing both physicians and insurance companies.
Search results for: health insurance
ACR Attends AMA House of Delegates
On Saturday, June 23, 2007, the American Medical Association (AMA) House of Delegates convened in Chicago; the meeting’s theme was advocacy. The ACR was represented by its delegate Melvin Britton, MD, and alternate delegate Gary Bryant, MD.
ACR Board Lobbies Congress
ACR Board of Directors members recently spent time in Washington, D.C., discussing rheumatology-related issues with members of Congress, including Sen. Edward M. “Ted” Kennedy (D-Mass.). The senior senator from Massachusetts is the chair of the Senate Health, Education, Labor, and Pensions Committee, which oversees health legislation that affects rheumatologists.
Medicare D-lemmas
Rheumatologists and patients report mixed experiences with the new prescription drug benefit
Rheumatology Influencers: Dr. Dave Has a Passion for Giving Back
Dr. Amish Dave discusses how his volunteer, advocacy & public outreach work stem from his greater commitment to community & helping others.
3 AC&R Study Summaries: Avoidable RA Hospitalizations, Psoriasis to Psoriatic Arthritis Transition, & Neighborhood Conditions in Childhood Lupus
New studies reveal predictors for avoidable RA hospitalizations, PsA transition in psoriasis & the impact of neighborhood on childhood lupus.
How the Experts Treat Sjögren’s Disease
With no FDA-approved drugs for Sjögren’s disease, experts share strategies for managing fatigue, arthritis, dryness, and systemic issues.
Medical Liability Reform Position Statement Now Addresses Harmful Payer Policies, Telemedicine Authorization & Patient Compensation
The largest changes include additions that address harmful payer policies, telemedicine authorization and patient compensation funds.
UHC Formulary Change Impacts Coverage for Ustekinumab
Effective Sept. 1, the brand name drug Stelara will no longer be covered on the UnitedHealthcare commercial plan prescription drug list.
White Bagging: A ‘Prescription for Disruption’ in Rheumatologic Care
In a recent op-ed published by MedCity News, rheumatologist and ACR Insurance Subcommittee Chair Michael Feely, MD, delivers a powerful critique of the insurance practice known as white bagging, calling it a “prescription for disruption” that threatens the quality and timeliness of patient care.
- « Previous Page
- 1
- …
- 51
- 52
- 53
- 54
- 55
- …
- 117
- Next Page »